Retatrutide

Retatrutide (LY3437943) is an investigational triple hormone receptor agonist that activates the GIP, GLP-1, and glucagon receptors. Published research has examined its relationship to energy balance, glucose regulation, lipid metabolism, body weight, and body composition. Research Focus • GIP, GLP-1, and glucagon signaling • Energy and glucose metabolism • Lipid metabolism and body composition This product is offered exclusively for laboratory research and is not intended for human or animal consumption, diagnostic use, therapeutic use, or clinical application.